Table 5

Diagnoses with numbers of QIs and QIs revealing non-adherence to the guidelines
Diagnosis n of cases with diagnosis (number of QIs) n of QIs revealing non-adherent treatment % QIs revealing non-adherent treatment (95% CI)
Arterial hypertension 424 (424) 69 16.3 (12.8-19.9)
Diabetes mellitus type 2 174 (174) 8 4.6 (1.5-7.7)
Heart failure 41 (89) 27 30.3 (20.8-39.9)
β-Blocker 41 (41) 15 36.6 (21.8-51.3)
RAAS-I 41 (41) 8 19.5 (7.4-31.6)
Aldo-A in NYHA III/IV 7 (7) 4 57.1 (20.5-93.8)
Atrial fibrillation 106 (106) 15 14.2 (7.5-20.8)
Cardiovascular disease 177 (431) 86 20.0 (16.2-23.7)
Statin 177 (177) 53 29.9 (23.2-36.7)
Platelet aggregation inhibitors 177 (177) 12 6.8 (3.1-10.5)
β-blocker after myocardial infarction 77 (77) 21 27.3 (17.3-37.2)
Total* 922 (1224) 205 16.8 (14.7-18.8)

* The number of diagnoses exceeds the number of patients as many subjects had more than one of the target diagnoses.

Fürthauer et al.

Fürthauer et al. BMC Family Practice 2013 14:47   doi:10.1186/1471-2296-14-47

Open Data